Abstract
The frequency of the APC I1307K mutation and its association with disease pattern was examined in 996 Ashkenazi women consisting of individuals with either sporadic (n = 382) or hereditary (n = 143) breast and/or ovarian cancer; asymptomatic BRCA1/2 mutation carriers (185delAG, 5382insC and 6174delT) (n = 53) and healthy controls (n = 418). The I1307K allele was equally distributed among women with sporadic (17/382; 4.6%) and inherited (10/143; 7%) breast and/or ovarian cancer irrespective of their being diagnosed before or after 42 years of age and among asymptomatic (7/53; 13.2%) and cancer manifesting BRCA1/2 carriers (10/143; 7%). Taken together, the prevalence of the I1307K allele was significantly higher in BRCA1/2 carriers compared to non-BRCA1/2 carriers (17/196; 8.7% and 40/800, 5%; respectively). The high prevalence of the I1307K allele among BRCA1/2 carriers is not associated with increased cancer risk but seems to be genetically connected because of Jewish ancestry. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Abeliovich D, Kaduri L, Lerer I, Weinberg N, Amir G, Sagi M, Zlotogora J, Heching N and Peretz T (1997) The founder mutations 185delAG and 5382insC in BRCA1 and 617delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am J Hum Genet 60: 501–514
Bruchim Bar-Sade R, Kruglikova A, Modan B, Gak E, Hirsch-Yechezkel G, Theodor L, Novikov I, Gershoni-Baruch R, Risel S, Papa MZ, Ben-Baruch G and Friedman E (1998) The 185delAG BRCA-1 mutation originated before the dispersion of Jews in The Diaspora and not limited to Ashkenazim. Hum Mol Genet 7: 801–806
Friedman LS, Szabo CI, Ostermeyer EA, Dowd P, Butler L, Park T, Lee MK, Goode EL, Sarah ER and King MC (1995) Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. Am J Hum Genet 57: 1284–1297
Israel Cancer Registry (1992) Cancer in Israel. Ministry of Health: Jerusalem
Kashiwaba M, Tamura G and Ishida MJ (1994) Aberrations of the APC gene in primary breast carcinoma. J Cancer Res Clin Oncol 120: 727–731
Laken SJ, Petersen GM, Gruber SB, Oddoux C, Ostrer H, Giardiello FM, Hamilton SR, Hampel H, Markowitz A, Klimstra D, Jhanwar S, Winawer S, Offit K, Luce MC, Kinzler KW and Vogelstein B (1997) Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nature Genet 17: 79–83
Lerman LS, Fischer SG, Hurley I, Silverstein K and Lumelsky N (1984) Sequence-determined DNA separations. Annu Rev Biophys Bioeng 13P: 399–423
Modan B, Gak E, Hirsch G, Bar-Sade Bruchim R, Theodor L, Lubin F, Ben-Baruch G, Beller U, Fishman A, Dgani R, Menczer J, Papa MZ and Friedman E (1996) High frequency of the 185delAG mutation in ovarian cancer in Israel. JAMA 76: 1823–1225
Myers RM, Maniatis T and Lerman LS (1987) Detection and localization of single base changes by denaturing gradient gel electrophoresis. Methods Enzymology, Wu R (ed.) pp 155, 501–527, Academic Press: San Diego
Neuhausen S, Gilewski T, Norton L, Tran T, McGuire P, Swensen J, Hampel H, Borgen P, Brown K, Skolnick M, Shattuck-Eidens D, Jhanwar S, Goldgar D and Offit K (1996) Recurrent BRCA2 617delT mutations in Ashkenazi Jewish women affected by breast cancer. Nature Genet 13: 126–128
Patael Y, Figer A, Gershoni-Baruch R, Papa MZ, Rizel S, Chen R and Karasik A (2000) A common origin of the I1307K APC polymorphism in Ashkenazi and non-Ashkenazi Jews. EJHG 7: 555–559
Petrukhin L, Dangel J, Vanderveer L, Costalas J, Bellacosa A, Grana G & Dali Godwin AK (1997) The I1307K APC mutation does not predispose to colorectal cancer in Jewish Ashkenazi breast and breast–ovarian cancer kindreds. Cancer Res 57: 5480–5484
Redston M, Nathanson KL, Yuan ZQ, Neuhausen SL, Satagopan J, Wong N, Yang D, Nafa D, Abrahamson J, Ozcellik H, Antin-Ozerkis D, Andrulis I, Daly M, Pinski L, Shrag D, Galinger S, Kaback M, King MC, Woodage T, Brody LC, Godwin A, Warner E, Weber B, Foulkes W and Offit K (1998) The APC I1307K allele and breast cancer risk. Nature Genet 20: 13–14
Rohlfs EM, Learning WG, Friedman KJ, Couch FJ, Weber BL and Silverman LM (1997) Direct detection of mutations in the breast and ovarian cancer susceptibility gene BRCA1 by PCR-mediated site-directed mutagenesis. Clin Chem 43: 24–29
Thompson AM, Morris RG, Wallase M, Willie AH, Steel CM and Carter DC (1993) Allele loss from 5q21 (APC-MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer. Br J Cancer 68: 64–68
Tonin P, Weber B, Offit K, Couch F, Rebbeck TR, Neuhausen S, Godwin AK, Daly M, Wagner-Costalos J, Berman D, Grana J, Fox E, Kane MF, Kolodner RD, Krainer M, Haber DA, Struewing JP, Warner E, Rosen B, Lerman C, Peshkin B, Norton L, Serova O, Foulkes WD and Graber JE (1996) Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nature Med 2: 1179–1183
Woodage T, King SM, Wacholder S, Hartge P, Struewing JP, McAdams M, Laken SJ, Tucker MA and Brody LC (1998) The APC I1307K allele and cancer risk in a community-based study of Ashkenazi Jews. Nature Genet 20: 62–65
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Gershoni-Baruch, R., Patael, Y., Dagan et al. Association of the I1307K APC mutation with hereditary and sporadic breast/ovarian cancer: more questions than answers. Br J Cancer 83, 153–155 (2000). https://doi.org/10.1054/bjoc.2000.1248
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2000.1248
Keywords
This article is cited by
-
Characterization of TP53-wildtype tubo-ovarian high-grade serous carcinomas: rare exceptions to the binary classification of ovarian serous carcinoma
Modern Pathology (2021)
-
Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis
Journal of Ovarian Research (2019)
-
EMSY promoted the growth and migration of ovarian cancer cells
Tumor Biology (2015)
-
An Analysis of Polymorphisms Within the Wnt Signaling Pathway in Relation to Ovarian Cancer Risk in a Polish Population
Molecular Diagnosis & Therapy (2014)
-
Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families
Familial Cancer (2010)